Holders

KINIKSA PHARMACEUTICALS INTL

Q4 2024 13F holders

CUSIP
G52694109
Type
Equity
Class
ORD SHS CL A
Total Reported Value ($000, excl. options)
Manager Report date Value ($000) Shares Option type